Nachrichten zur Bausch Health Companies Inc. Aktie

Bausch Health Companies Inc. 2024 Q3 - Results - Earnings Call Presentation

…

Bausch Health Companies, Inc. (BHC) Q3 2024 Earnings Call Transcript

…

Global Diabetes Associated Ophthalmic Treatment Market Size To Exceed USD 56.43 Billion By 2033 l CAGR Of 6.61%

The Global Diabetes Associated Ophthalmic Treatment Market Size was Valued at USD 29.75 Billion in 2023 and the Worldwide Diabetes…

Bausch Health Companies (BHC) Q2 2024 Earnings Call Transcript

…

Bausch Health Companies Inc. 2024 Q2 - Results - Earnings Call Presentation

…

2 Red Alerts On Bausch Health Companies

…

Global Herpes Treatment Market Size To Worth USD 1.87 Billion By 2033 | CAGR Of 4.28%

The Global Herpes Treatment Market Size was Valued at USD 1.23 Billion in 2023 and the Worldwide Herpes Treatment Market…

Global Pleural Diseases Market Size To Exceed USD 9.61 Billion By 2033 | CAGR Of 6.75%

The Global Pleural Diseases Marke Size was Valued at USD 5.0 Billion in 2023 and the Worldwide Pleural Diseases Market…

Canadian Pharma Stocks: 5 Biggest Companies in 2024

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription…

Bausch Health Companies Inc. 2024 Q1 - Results - Earnings Call Presentation

…

Bausch Health Companies (BHC) Q4 2023 Earnings Call Transcript

…

Top 3 Canadian Pharma Stocks

From established players to up-and-coming biotech firms, the Canadian pharmaceutical landscape is diverse and dynamic.As we look ahead to 2024,…

IRW-News: Bausch Health Companies Inc.: KORREKTUR DURCH QUELLE: Thermage(R) FLX und TR-4 Return Pad von Solta Medical erhalten Registrierungszertifikate in China

IRW-PRESS: Bausch Health Companies Inc.: KORREKTUR DURCH QUELLE: Thermage(R) FLX und TR-4 Return Pad von Solta…

Implied Volatility Surging for On Bausch Health Companies (BHC) Stock Options

Investors need to pay close attention to Bausch Health Companies (BHC) stock based on the movements in the options market…

[Latest] Global Acne Treatment Market Size/Share Worth USD 18.77 Billion by 2032 at a 6.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

Global Actinic Keratosis Treatment Market Size To Grow USD 9.7 Billion by 2032 | CAGR of 5.8%

The Global Actinic Keratosis Treatment Market Size was valued at USD 5.5 Billion in 2022 and the Worldwide Actinic Keratosis…

Bausch Health Companies Inc. (BHC) Q3 2023 Earnings Call Transcript

…

Bausch Health Companies Inc. 2023 Q3 - Results - Earnings Call Presentation

…

Bausch Health Companies Q3 2023 Earnings Preview

…

Active Pharmaceutical Ingredients (API) Market Size to Surpass USD 349.2 Billion Growth by 2030, Exhibit a CAGR of 6.5%

[235 + Pages Report] According to a market research study published by The Brainy Insights, the demand analysis of Global…

Mucous Membrane Decontamination Market revenue to surpass USD 15 Billion by 2035, says Research Nester

Major mucous membrane decontamination market players include Astellas Pharma Inc., Bausch Health Companies Inc., Genentech, Inc., Lipidor AB., Pfizer Inc.,…

Specialty Generics Market to Reach USD 184.8 Billion by 2032; Increasing Capacity for Walking & Physical Activities to Propel Growth, says The Brainy Insights

Global specialty generics market size from USD 70.0 billion in 2022 to USD 184.8 billion, growing at a CAGR of…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

Ophthalmic Drugs Market Aims for Remarkable Growth, Targeting USD 62.67 Billion by 2032 at 6% CAGR

The global ophthalmic drugs market size is anticipated to grow from USD 35 billion to USD 62.67 billion in 10…

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Bausch Health Companies Inc.(BHC) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Bausch Health Companies…

IBD (Ulcerative Colitis and Crohns Disease) Treatment Market revenue to hit USD 36 Billion by 2033, says Research Nester

Leading IBD (Ulcerative Colitis and Crohns Disease) Treatment Market players include Bausch Health Companies Inc., AbbVie Inc., Novartis AG, Bristol…

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bausch Health Companies Inc. (BHC)

LOS ANGELES, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…

BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.

NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Bausch Health Companies Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 – (NYSE: BHC)

NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action – BHC

NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bausch, Applied Digital, and Infinity and Encourages Investors to Contact the Firm

NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.

NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:…

BHC Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed against Bausch Health Companies Inc. (BHC)

RADNOR, Pa., Sept. 11, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bausch Health Companies Inc. (BHC)

LOS ANGELES, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC

NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Bausch Health Companies Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 – (NYSE: BHC)

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

Form 10-Q Bausch Health Companies For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bausch Health rises on earnings beat, 2023 revenue outlook boost

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bausch Health (BHC) Beats Q2 Earnings and Revenue Estimates

Bausch (BHC) delivered earnings and revenue surprises of 8% and 6.03%, respectively, for the quarter ended June 2023. Do the…

Bausch Health Companies GAAP EPS of $0.07 beats by $0.12, revenue of $2.17B beats by $130M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bausch Health Companies Inc: Bausch Health Announces Second-Quarter 2023 Results, Other Key Updates From the Quarter, and Raises Full-Year 2023 Revenue Outlook

Favorable Motion Ruling in Xifaxan® Litigation Reinforces Continuing Salix Growth StrategyBalance Sheet Initiatives Further Enhance Liquidity ProfileContinued Evaluation of Optimal…

dpa-AFX ProFeed